Marker Therapeutics (MRKR) Change in Receivables (2011 - 2026)
Marker Therapeutics (MRKR) reported Change in Receivables of $7900.0 for Q1 2026, down 92.95% year-over-year from $112062.0 in Q1 2025, and down 92.95% quarter-over-quarter from $112062.0 in Q1 2025.
Marker Therapeutics (MRKR) Change in Receivables (2011 - 2026) Analysis & Trends
Marker Therapeutics (MRKR) has 4 years of Change in Receivables data on file, last reported at $7900.0 in Q1 2026.
- Change in Receivables for Q1 2026 came in at $7900.0, down 92.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $119962.0 (up 7.11% YoY), and the FY2025 annual result was -$977303.0, down 174.1% from the prior year.
- Change in Receivables slipped to $7900.0 in Q1 2026 per MRKR's latest filing, from $112062.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $112062.0 in Q1 2025 and troughed at $7900.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | 7,900.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,900.00 |
| Mar 31, 2026 | 7,900.00 |
| Mar 31, 2025 | 112,062.00 |
| Mar 31, 2025 | 112,062.00 |
| Jun 30, 2012 | -24.00 |
| Jun 30, 2012 | -24.00 |
| Mar 31, 2012 | 24.00 |
| Mar 31, 2012 | 24.00 |
| Jun 30, 2011 | -65.00 |
| Jun 30, 2011 | -65.00 |
| Mar 31, 2011 | 65.00 |
| Mar 31, 2011 | 65.00 |